| CDJAX | MBXCX | CDJAX / MBXCX | |
| Total Expense Ratio | 0.77 | 3.00 | 26% |
| Annual Report Gross Expense Ratio | 0.77 | 3.00 | 26% |
| Fund Existence | 5 years | 11 years | - |
| Gain YTD | 8.522 | 16.456 | 52% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.34B | 11.1B | 21% |
| Annual Yield % from dividends | 1.32 | 0.00 | - |
| Returns for 1 year | 6.66 | 18.01 | 37% |
| Returns for 3 years | 50.35 | 27.93 | 180% |
| Returns for 5 years | 33.66 | 37.27 | 90% |
| Returns for 10 years | N/A | 86.25 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TLVIX | 38.37 | 0.34 | +0.89% |
| Thrivent Large Cap Value S | |||
| MCEFX | 12.85 | 0.11 | +0.86% |
| BlackRock International Select Eq Inv C | |||
| ADCCX | 16.55 | 0.13 | +0.79% |
| American Century Disciplined Growth C | |||
| VMVAX | 105.61 | N/A | N/A |
| Vanguard MStar Mid Cap Value Index Adm | |||
| PLJMX | 65.24 | N/A | N/A |
| Putnam U.S. Research R6 | |||